X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4970) 4970
Publication (305) 305
Book Chapter (18) 18
Book Review (12) 12
Book / eBook (5) 5
Conference Proceeding (5) 5
Newspaper Article (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
carbon radioisotopes (3412) 3412
animals (3326) 3326
male (2857) 2857
humans (2052) 2052
rats (1892) 1892
female (1459) 1459
tissue distribution (1364) 1364
index medicus (1060) 1060
pharmacology & pharmacy (921) 921
carbon radioisotopes - pharmacokinetics (851) 851
mice (850) 850
adult (819) 819
brain - metabolism (808) 808
rats, sprague-dawley (639) 639
brain - diagnostic imaging (626) 626
pet (598) 598
kinetics (595) 595
metabolism (580) 580
middle aged (577) 577
positron emission tomography (555) 555
radiopharmaceuticals - pharmacokinetics (519) 519
radiology, nuclear medicine & medical imaging (500) 500
administration, oral (499) 499
neurosciences (452) 452
positron-emission tomography (450) 450
tomography, emission-computed (447) 447
time factors (445) 445
positron-emission tomography - methods (420) 420
pharmacokinetics (416) 416
toxicology (410) 410
autoradiography (378) 378
brain (374) 374
liver - metabolism (363) 363
chromatography, high pressure liquid (353) 353
tritium (348) 348
injections, intravenous (334) 334
positron-emission-tomography (333) 333
dose-response relationship, drug (327) 327
rats, wistar (326) 326
aged (317) 317
rats, inbred strains (316) 316
feces - chemistry (286) 286
in-vivo (277) 277
biochemistry & molecular biology (265) 265
metabolic clearance rate (260) 260
biotransformation (259) 259
dogs (246) 246
absorption (244) 244
half-life (237) 237
models, biological (235) 235
binding (232) 232
in vitro techniques (220) 220
rat (217) 217
oncology (211) 211
carbon radioisotopes - chemistry (202) 202
protein binding (197) 197
biological availability (187) 187
reproducibility of results (185) 185
brain - drug effects (183) 183
radiopharmaceuticals - chemical synthesis (182) 182
chemistry, medicinal (176) 176
article (171) 171
biological transport (171) 171
rodents (170) 170
carbon radioisotopes - metabolism (169) 169
endocrinology & metabolism (168) 168
ligands (168) 168
kidney - metabolism (163) 163
radionuclide imaging (160) 160
physiology (159) 159
metabolites (158) 158
sensitivity and specificity (158) 158
liver (157) 157
mass spectrometry (156) 156
macaca mulatta (152) 152
drugs (150) 150
expression (150) 150
isotope labeling (149) 149
medicine & public health (149) 149
organic compounds (148) 148
blood-brain barrier (147) 147
intestinal absorption (145) 145
area under curve (141) 141
species specificity (141) 141
rabbits (140) 140
rats, inbred f344 (140) 140
pet imaging (138) 138
physiological aspects (137) 137
young adult (137) 137
cells, cultured (136) 136
labelled compounds (136) 136
transport (136) 136
myocardium - metabolism (133) 133
excretion (132) 132
bile - metabolism (131) 131
tomography, emission-computed - methods (131) 131
basic biological sciences (130) 130
toxicity (129) 129
analysis (128) 128
mammals (128) 128
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4854) 4854
German (70) 70
French (48) 48
Russian (30) 30
Japanese (27) 27
Chinese (9) 9
Ukrainian (8) 8
Spanish (7) 7
Hungarian (6) 6
Polish (5) 5
Czech (2) 2
Italian (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
NeuroImage, ISSN 1053-8119, 04/2016, Volume 130, pp. 167 - 174
[ C]Cimbi-36 is a recently developed serotonin 2A (5-HT ) receptor agonist positron emission tomography (PET) radioligand that has been successfully applied... 
Neuroimaging | Agonist | 5-HT | Positron emission tomography | Radiotracer evaluation | Test–retest variability | Test-retest variability | SURFACE-BASED ANALYSIS | SYSTEM | LOCALIZATION | BOLUS/INFUSION APPROACH | QUANTIFICATION | BEHAVIOR | 5-HT2A RECEPTOR | RATS | NEUROSCIENCES | POSITRON-EMISSION-TOMOGRAPHY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PET RADIOLIGAND | Serotonin 5-HT2 Receptor Agonists - pharmacokinetics | Humans | Ketanserin - analogs & derivatives | Male | Benzylamines - metabolism | Brain - metabolism | Young Adult | Radiopharmaceuticals - metabolism | Fluorine Radioisotopes - pharmacokinetics | Phenethylamines - pharmacokinetics | Female | Serotonin 5-HT2 Receptor Agonists - metabolism | Neuroimaging - methods | Reproducibility of Results | Radiopharmaceuticals - pharmacokinetics | Carbon Radioisotopes - pharmacokinetics | Phenethylamines - metabolism | Positron-Emission Tomography - methods | Serotonin 5-HT2 Receptor Antagonists - pharmacokinetics | Ketanserin - metabolism | Ketanserin - pharmacokinetics | Serotonin 5-HT2 Receptor Antagonists - metabolism | Fluorine Radioisotopes - metabolism | Carbon Radioisotopes - metabolism | Benzylamines - pharmacokinetics | Phenols | Brain | Serotonin | Analysis | Choroid plexus | Medical imaging | Lysergic acid diethylamide--LSD | Cortex | Radioisotopes | Serotonin S2 receptors | Tomography | Receptor density | Agonists | Hippocampus
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2015, Volume 112, Issue 40, pp. 12468 - 12473
Journal Article
Journal Article
Chemical Research in Toxicology, ISSN 0893-228X, 03/2012, Volume 25, Issue 3, pp. 532 - 542
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 2/2017, Volume 56, Issue 2, pp. 179 - 192
Journal Article
Neurology, ISSN 0028-3878, 01/2005, Volume 64, Issue 2, pp. 208 - 215
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 07/2007, Volume 48, Issue 7, pp. 1180 - 1189
Journal Article
ACS Nano, ISSN 1936-0851, 08/2015, Volume 9, Issue 8, pp. 7950 - 7959
Journal Article
JAMA Neurology, ISSN 2168-6149, 01/2017, Volume 74, Issue 1, pp. 67 - 74
Journal Article
Investigational New Drugs, ISSN 0167-6997, 6/2018, Volume 36, Issue 3, pp. 407 - 415
This two-part, phase I study evaluated the mass balance, excretion, pharmacokinetics (PK), and safety of ixazomib in patients with advanced solid tumors. In... 
Mass balance | Medicine & Public Health | ADME | AMS | Total radioactivity | Oncology | Pharmacology/Toxicology | Pharmacokinetics | Ixazomib | DEXAMETHASONE | SAFETY | BORTEZOMIB | RENAL IMPAIRMENT | RELAPSED/REFRACTORY MULTIPLE-MYELOMA | ONCOLOGY | DRUGS | Pharmacolcinetics | LENALIDOMIDE | PHARMACOLOGY & PHARMACY | SPECTROMETRY | BLOOD | Carbon Radioisotopes - blood | Glycine - analogs & derivatives | Glycine - therapeutic use | Humans | Middle Aged | Male | Boron Compounds - administration & dosage | Female | Feces | Carbon Radioisotopes - administration & dosage | Proteasome Inhibitors - blood | Glycine - administration & dosage | Proteasome Inhibitors - pharmacokinetics | Radioactivity | Glycine - pharmacokinetics | Urine | Glycine - blood | Administration, Oral | Carbon Radioisotopes - pharmacokinetics | Proteasome Inhibitors - administration & dosage | Boron Compounds - pharmacokinetics | Treatment Outcome | Proteasome Inhibitors - therapeutic use | Neoplasms - drug therapy | Aged | Neoplasm Staging | Neoplasms - pathology | Boron Compounds - blood | Boron Compounds - therapeutic use | Excretion | Oral administration | Mass spectroscopy | Pharmacology | Patients | Proteasome inhibitors | Studies | Metabolites | Gastrointestinal system | Solid tumors | Mass spectrometry | Carbon 14 | Drug dosages | Tumors | Phase I Studies
Journal Article
NeuroImage, ISSN 1053-8119, 02/2010, Volume 49, Issue 4, pp. 2924 - 2932
Journal Article